Covaxin has demonstrated protective efficacy and immunogenicity in non-human primates in Phase I clinical trials in India. Covaxin, the indigenously developed Covid-19 vaccine, developed by the ICMR and Bharat Biotech International, is being tested at 12 ...
from Google Alert - health https://ift.tt/2RpJFpj
via IFTTT
0 comments:
Post a Comment